How much funding has Qpex Biopharma raised?

Qpex Biopharma has raised $33.0M in total funding, most recently a Series A round.

Who are Qpex Biopharma's investors?

Qpex Biopharma's investors include Shionogi, New Enterprise Associates, Adams Street Partners, Hatteras Venture Partners, LYZZ Capital.

When was Qpex Biopharma founded?

Qpex Biopharma was founded in 2018.

Where is Qpex Biopharma headquartered?

Qpex Biopharma is headquartered in San Diego, California, United States.

What industry is Qpex Biopharma in?

Qpex Biopharma operates in Biotech, Infectious Diseases.

Qpex Biopharma

Acquired

Innovating Treatments To Address the Global Public Health Burden of Infectious Diseases.

San Diego, United States · Founded 2018 · $33.0M raised

Biotech

Infectious Diseases

Headquarters: San Diego, California
Founded: 2018
Business Model: B2B
Website: qpexbio.com

Total Funding: $33.0M
Last Round: $33.0M Series AOct 2018
Rounds: 1
Acquisition Date: Jun 2023

About

Qpex Biopharma, now a Shionogi Group Company, is a resistance-focused infectious disease company developing a pipeline of novel antibiotics and anti-infectives targeting drug-resistant bacterial pathogens. The company focuses on developing clinically proven treatments for critically resistant gram-negative organisms, addressing the global public health crisis of antimicrobial resistance. Qpex has partnered with BARDA to advance its antibiotic portfolio.

Summary

Qpex Biopharma is a Biotech company based in San Diego, United States, founded in 2018. It has raised $33.0M in total across 1 round, most recently a $33.0M Series A round in Oct 2018. Investors include Shionogi, New Enterprise Associates and Adams Street Partners.

LinkedIn X (Twitter)